(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

2-Bromo-4-chlorothiazole, 95.0%, 250mg

Methyl 4-aminopyrimidine-5-carboxylate, 95.0%, 25g

1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g

1-(4-Fluorobenzyl)piperazine>95.0%(HPLC)(T)5g

Ethylene glycol monobutyl ether, 99% min, for synthesis, 2.5 L, glass packaging

Tert-butyl 4-(aminomethyl)-2-benzyl-2,8-diazaspiro[4.5]Decane-8-carboxylate, 97%, 1g

2-(Trifluoromethyl)terephthalic acid, 95.0%, 5g

(cis-1-Benzylpyrrolidine-2,5-diyl)dimethanol, 95.0%, 250mg

4-Bromo-2-methylbenzaldehyde, 98.0%, 5g

4-Hydroxyphthalic Acid>98.0%(T)5g

Methyl (2R,3R)-2-phenylpyrrolidine-3-carboxylate hydrochloride, 97%, 2g

(2-methylphenyl)methanol, 95.0%, 25g